Protective Effect of Combined Metoprolol and Atractylenolide I in Rats with Acute Myocardial Infarction via Modulation of the SIRT3/β-CATENIN/PPAR-γ Signaling Pathway-Reference-Cited by-同舟云学术

Protective Effect of Combined Metoprolol and Atractylenolide I in Rats with Acute Myocardial Infarction via Modulation of the SIRT3/β-CATENIN/PPAR-γ Signaling Pathway

Published:2023 Issue: Volume:59 Page:
ISSN:2175-9790
Container-title:Brazilian Journal of Pharmaceutical Sciences
language:
Short-container-title:Braz. J. Pharm. Sci.

Author:

Zhou Weijian¹,Liu Jing²,Sun Zhongli³,Dong Yongpeng⁴,Zhu Meiming⁵,Li Li⁶^ORCID

Affiliation:

1. Weihai Municipal Hospital, China

2. Yantai Affiliated Hospital of Binzhou Medical University, China

3. Liaocheng People’s Hospital, China; Liaocheng People’s Hospital, China

4. Binzhou Hospital of Traditional Chinese Medicine, China

5. Weiji Town Health Center, China

6. Zibo Central Hospital, China

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S1984-82502023000100350&tlng=en

Reference59 articles.

1. Long-term pharmacological management of reduced ejection fraction following acute myocardial infarction: Current status and future prospects;Abel AAI;Int J Gen Med,2021

2. The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells;Albrecht-Schgoer K;Circulation,2012

3. Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review;Bosco E;BMC Med Res Methodol,2021

4. Endothelial actions of ANP enhance myocardial inflammatory infiltration in the early phase after acute infarction;Chen W;Circ Res,2016

5. Association of β-Blocker therapy at discharge with clinical outcomes after acute coronary syndrome in patients without heart failure;Chen Y;Cardiovasc Ther,2020